ATC 2013: Does Adding Rituximab to IVIg and Plasmapheresis Improve Outcome of AMR? 1-Yr Results of RITUX-ERAH Study
Does adding rituximab to IVIg and plasmapheresis improve outcome of antibody mediated rejection? One year results of the RITUX-ERAH study. In transplant and nephrology, the [...]